SEMA3A and eye disorder: As a component of PNNs, Sema3A has a role in ischemic retinopathies and retinal ganglion cells (RGCs) apoptosis in eye diseases [24,25]; thus, Sema3A could be a target for molecular approaches to treat for microvascular disorders in the eye and brain [26,27,28,29,30].